Search Results - "Salvà Ballabrera, F."

Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept by González Astorga, B., Salvà Ballabrera, F., Aranda Aguilar, E., Élez Fernández, E., García-Alfonso, P., González Flores, E., Vera García, R., Fernández Montes, A., López Muñoz, A. M., Salud Salvia, A.

“…Colorectal cancer is the second leading cause of cancer-related death worldwide. For metastatic colorectal cancer (mCRC) patients, it is recommended, as…”
Get full text

626P Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations by Ros Montana, F.J., Navarro, V., Comas, R., Landolfi, S., Ramirez, L., Palmer, H.G., Garcia Rodriguez, A., Saoudi Gonzalez, N., Baraibar Argota, I., Rodriguez Castells, M., Salvà Ballabrera, F., Tabernero, J., Elez Fernandez, M.E.

Get full text

374P Influence of sex on safety and efficacy in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with encorafenib-cetuximab +/-binimetinib (E-C+/-B) by Ros Montana, F.J., Navarro, V., Comas, R., Garcia Rodriguez, A., Gomez, D., Saoudi Gonzalez, N., Vicente, P., Cuadra, J.L., Paez, D., Alonso, V., Hernandez Martinez, A., López Valbuena, D.E., Baraibar Argota, I., Salvà Ballabrera, F., Tabernero, J., Elez Fernandez, M.E.

Get full text

357P Novel potential predictive biomarker to immunotherapy (Io) treatment in metastatic colorectal cancer (mCRC) patients: The role of the VHIO immune gene-expression signature (VIGex) by Saoudi Gonzalez, N., Vila Casadesus, M., Ros Montana, F.J., Baraibar Argota, I., Salvà Ballabrera, F., Garcia Rodriguez, A., López Valbuena, D.E., Gómez-Puerto, D., Hernando-Calvo, A., Tabernero, J., Vivancos, A., Elez Fernez, M.E.

Get full text

CN52 Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects by Rodriguez, A. Garcia, Castillo, G., Argota, I. Baraibar, Sanchis, M., Sanz, M., Suarez, I., Ballabrera, F. Salvà, Montana, F.J. Ros, Gonzalez, N. Saoudi, Valdivia, A.A., Alonso, C. Perez, Rosales, C., Texidor, A., Castells, M. Rodriguez, Gallostra, M. Marti, Saiz, A. Peñuelas, Tabernero, J., Fernandez, M.E. Elez

Get full text

332P Impact of the COVID-19 pandemic in the early-onset colorectal cancer (EOCRC) by Baraibar Argota, I., Garcia Rodriguez, A., Salvà Ballabrera, F., Ros Montana, F.J., Saoudi Gonzalez, N., Comas, R., Castillo, G., Sanchis, M., Hernando Cubero, J., García-Alvarez, A., Capdevila Castillon, J., Martí, M., Landolfi, S., Espin, E., Nuciforo, P.G., Vivancos, A., Tabernero, J., Elez Fernandez, M.E.

Get full text

6P Circulating tumor DNA (ctDNA) next generation sequencing (NGS): Molecular prescreening for tailoring treatment in clinical trials by Alonso, G., Aguilar, S., Ros Montana, F.J., Verdaguer, H., Callejo Perez, A., Brana, I., Baraibar Argota, I., Iranzo Gomez, P., Saavedra Santa Gadea, O., Salva Ballabrera, F., Acosta Eyzaguirre, D.A., Vieito Villar, M., Garcia Torralba, E., Wornham, N.A., Faull, I., Tabernero, J., Felip, E., Elez, E., Macarulla Mercade, T., Garralda, E.

Get full text